Multicentre randomized-controlled clinical trial of Ipocol, a new enteric-coated form of mesalazine, in comparison with Asacol in the treatment of ulcerative colitis. uri icon

authors

  • Forbes, A
  • Al-Damluji, A
  • Ashworth, S
  • Bramble, M
  • Herbert, K
  • Ho, J
  • Kang, J-Y
  • Przemioslo, R
  • Shetty, A

publication date

  • January 1, 2005